Case Report: Hemophagocytic lymphohistiocytosis secondary to Escherichia coli infiltration of bone marrow in a patient with seronegative rheumatoid arthritis treated with low-dose methotrexate - Summary - MDSpire
Advertisement
Case Report: Hemophagocytic lymphohistiocytosis secondary to Escherichia coli infiltration of bone marrow in a patient with seronegative rheumatoid arthritis treated with low-dose methotrexate
To present a case of hemophagocytic lymphohistiocytosis (HLH) secondary to Escherichia coli infection in a seronegative rheumatoid arthritis patient on low-dose methotrexate.
Approach:
Diagnostic Evaluation: Bone marrow aspiration revealed active hemophagocytosis with phagocytosis of E. coli, confirming the diagnosis of HLH.
Key Findings:
The patient exhibited severe pancytopenia and systemic inflammation.
Bone marrow analysis showed 20% active hemophagocytosis with E. coli.
HLH was suspected due to elevated cytokine levels and laboratory abnormalities.
Interpretation:
The case highlights the potential for E. coli infections to induce HLH, particularly in immunocompromised patients.
Limitations:
The case is a single patient report, limiting generalizability.
Further studies are needed to understand the mechanisms linking E. coli to HLH.
Conclusion:
HLH can occur in the context of E. coli infections, especially in patients with underlying immunosuppression.